Showing results 22 to 30 of 30
< previous
| Issue Date | Title | Author(s) |
| 2018-06-15 | Network modeling of microRNA-mRNA interactions in neuroblastoma tumorigenesis identifies miR-204 as a direct inhibitor of MYCN | Ooi, CY; Carter, DR; Liu, B; Mayoh, C; Beckers, A; Lalwani, A; Nagy, Z; De Brouwer, S; Decaesteker, B; Hung, TT; Norris, MD; Haber, M; Liu, T; De Preter, K; Speleman, F; Cheung, BB; Marshall, GM |
| 2021-07-06 | Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia | Van Thillo, Q; De Bie, J; Seneviratne, JA; Demeyer, S; Omari, S; Balachandran, A; Zhai, V; Tam, WL; Sweron, B; Geerdens, E; Gielen, O; Provost, S; Segers, H; Boeckx, N; Marshall, GM; Cheung, BB; Isobe, K; Kato, I; Takita, J; Amos, TG; Deveson, IW; McCalmont, H; Lock, RB; Oxley, EP; Garwood, MM; Dickins, RA; Uyttebroeck, A; Carter, DR; Cools, J; de Bock, CE |
| 2023-06-23 | Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine Trial. | Daly, R; Hetherington, K; Hazell, E; Wadling, BR; Tyrrell, V; Tucker, KM; Marshall, GM; Ziegler, DS; Lau, LMS; Trahair, TN; O'Brien, TA; Collins, K; Gifford, AJ; Haber, M; Pinese, M; Malkin, D; Cowley, MJ; Karpelowsky, J; Drew, D; Jacobs, C; Wakefield, CE |
| 2022-09-15 | Prospective longitudinal evaluation of treatment-related toxicity and health-related quality of life during the first year of treatment for pediatric acute lymphoblastic leukemia. | Schilstra, CE; McCleary, K; Fardell, JE; Donoghoe, MW; McCormack, E; Kotecha, RS; Lourenco, RDA; Ramachandran, S; Cockcroft, R; Conyers, R; Cross, S; Dalla-Pozza, L; Downie, P; Revesz, T; Osborn, M; Alvaro, F; Wakefield, CE; Marshall, GM; Mateos, MK; Trahair, TN |
| 2011-12-01 | Reduced incidence of second solid tumors in survivors of childhood Hodgkin's lymphoma treated without radiation therapy | Barbaro, PM; Johnston, K; Dalla-pozza, L; Cohn, RJ; Wang, YA; Marshall, GM; Ziegler, DS |
| 2022-10-04 | Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory. | Yuan, X; Seneviratne, JA; Du, S; Xu, Y; Chen, Y; Jin, Q; Jin, X; Balachandran, A; Huang, S; Xu, Y; Zhai, Y; Lu, L; Tang, M; Dong, Y; Cheung, BB; Marshall, GM; Shi, W; Carter, DR; Zhang, C |
| 2021-03 | Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy. | Chen, J; Nelson, C; Wong, M; Tee, AE; Liu, PY; La, T; Fletcher, JI; Kamili, A; Mayoh, C; Bartenhagen, C; Trahair, TN; Xu, N; Jayatilleke, N; Wong, M; Peng, H; Atmadibrata, B; Cheung, BB; Lan, Q; Bryan, TM; Mestdagh, P; Vandesompele, J; Combaret, V; Boeva, V; Wang, JY; Janoueix-Lerosey, I; Cowley, MJ; MacKenzie, KL; Dolnikov, A; Li, J; Polly, P; Marshall, GM; Reddel, RR; Norris, MD; Haber, M; Fischer, M; Zhang, XD; Pickett, HA; Liu, T |
| 2019-11-05 | The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35. | Liu, PY; Tee, AE; Milazzo, G; Hannan, KM; Maag, J; Mondal, S; Atmadibrata, B; Bartonicek, N; Peng, H; Ho, N; Mayoh, C; Ciaccio, R; Sun, Y; Henderson, MJ; Gao, J; Everaert, C; Hulme, AJ; Wong, M; Lan, Q; Cheung, BB; Shi, L; Wang, JY; Simon, T; Fischer, M; Zhang, XD; Marshall, GM; Norris, MD; Haber, M; Vandesompele, J; Li, J; Mestdagh, P; Hannan, RD; Dinger, ME; Perini, G; Liu, T |
| 2020-11-12 | Withaferin A activates TRIM16 for its anti-cancer activity in melanoma. | Nagy, Z; Cheung, BB; Tsang, W; Tan, O; Herath, M; Ciampa, OC; Shadma, F; Carter, DR; Marshall, GM |
